Autoreactive napsin A–specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autoreactive napsin A–specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade
Authors
Keywords
-
Journal
Science Immunology
Volume 7, Issue 75, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-09-03
DOI
10.1126/sciimmunol.abn9644
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses
- (2021) Jennifer A. Lo et al. Science Translational Medicine
- HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
- (2021) Ana Marcu et al. Journal for ImmunoTherapy of Cancer
- Integrated analysis of multimodal single-cell data
- (2021) Yuhan Hao et al. CELL
- Comprehensive T cell repertoire characterization of non-small cell lung cancer
- (2020) Alexandre Reuben et al. Nature Communications
- Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening
- (2020) Huang Huang et al. NATURE BIOTECHNOLOGY
- Moving towards personalized treatments of immune-related adverse events
- (2020) Khashayar Esfahani et al. Nature Reviews Clinical Oncology
- Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
- (2019) Yucai Wang et al. JAMA Oncology
- Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer
- (2019) Fiamma Berner et al. JAMA Oncology
- Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors
- (2019) Fausto Petrelli et al. JOURNAL OF IMMUNOTHERAPY
- Vitiligo under anti-PD1 therapy is associated with increased survival in melanoma patients
- (2019) Charlée Nardin et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Fast, sensitive and accurate integration of single-cell data with Harmony
- (2019) Ilya Korsunsky et al. NATURE METHODS
- Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors
- (2019) Sophia C Weinmann et al. RHEUMATOLOGY
- Induction of Neoantigen-specific Cytotoxic T Cells and Construction of T-cell Receptor-engineered T cells for Ovarian Cancer
- (2018) Tatsuo Matsuda et al. CLINICAL CANCER RESEARCH
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- A flexible MHC class I multimer loading system for large-scale detection of antigen-specific T cells
- (2018) Jolien J. Luimstra et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
- (2018) Tatjana Bilich et al. BLOOD
- Tools to define the melanoma-associated immunopeptidome
- (2017) Eva Bräunlein et al. IMMUNOLOGY
- NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
- (2017) Vanessa Jurtz et al. JOURNAL OF IMMUNOLOGY
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- The human protein atlas: A spatial map of the human proteome
- (2017) Peter J. Thul et al. PROTEIN SCIENCE
- Neutrophils dominate the immune cell composition in non-small cell lung cancer
- (2017) Julia Kargl et al. Nature Communications
- SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity
- (2017) Jungsun Park et al. Cancer Immunology Research
- Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer
- (2016) Mizuki Nishino et al. JAMA Oncology
- Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
- (2015) Anne Bertrand et al. BMC Medicine
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melanocytes in the Skin – Comparative Whole Transcriptome Analysis of Main Skin Cell Types
- (2014) Paula Reemann et al. PLoS One
- HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
- (2014) Daniel J. Kowalewski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing
- (2013) Shengli Song et al. Cellular & Molecular Immunology
- The Effect of Proteasome Inhibition on the Generation of the Human Leukocyte Antigen (HLA) Peptidome
- (2013) Elena Milner et al. MOLECULAR & CELLULAR PROTEOMICS
- Napsin A, a New Marker for Lung Adenocarcinoma, Is Complementary and More Sensitive and Specific Than Thyroid Transcription Factor 1 in the Differential Diagnosis of Primary Pulmonary Carcinoma: Evaluation of 1674 Cases by Tissue Microarray
- (2012) Bradley M. Turner et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Quantitative signal detection using spontaneous ADR reporting
- (2009) A. Bate et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started